Literature DB >> 35510751

cDCDD-NRP is consistent with US legal standards for determining death.

Bradley L Adams1, Lauren Brenner2, Macey Levan3, Brendan Parent4.   

Abstract

Donation after circulatory determination of death (DCDD) has increased organ donation rates in the US over the past decade within an established legal framework, which is consistent with and supports individual and family decisions regarding organ donation in the context of end-of-life care. A new application, controlled DCDD donation utilizing thoracoabdominal normothermic regional perfusion (NRP) protocols (cDCDD-NRP), provides the opportunity to maximize a donation decision by recovering additional organs for transplant, including the heart, and to limit the detrimental impact of warm ischemic time by perfusing organs in situ following the declaration of circulatory death. In this viewpoint, we narrate our rationale for why cDCDD-NRP is consistent within the existing legal framework for organ donation in the United States and recommend no changes to the Uniform Determination of Death Act.
© 2022 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Uniform Anatomical Gift Act; Uniform Determination of Death Act; controlled donation after circulatory determination of death; donation after circulatory determination of death; normothermic regional perfusion

Mesh:

Year:  2022        PMID: 35510751     DOI: 10.1111/ajt.17083

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   9.369


  2 in total

1.  Partially revived pig organs could force a rethink of critical-care processes.

Authors:  Brendan Parent
Journal:  Nature       Date:  2022-08       Impact factor: 69.504

Review 2.  Normothermic Regional Perfusion is an Emerging Cost-Effective Alternative in Donation After Circulatory Death (DCD) in Heart Transplantation.

Authors:  Emad Alamouti-Fard; Pankaj Garg; Ishaq J Wadiwala; John H Yazji; Mohammad Alomari; Md Walid Akram Hussain; Mohamed S Elawady; Samuel Jacob
Journal:  Cureus       Date:  2022-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.